2 completed, 1 unknown. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Posterior Uveitis: new trials by email Literature Review of Posterior Uveitis trials Research Report on Posterior Uveitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study Tocilizumab - Intermediate Uveitis, Posterior Uveitis | Phase 1 / Phase 2 | Unknown | University of Nebraska | 36 | 2013-03-01 | 2017-04-28 |
| Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis triamcinolone acetonide (Triesence®) - Uveitis, Intermediate Uveitis | Phase 1 / Phase 2 | Completed | Clearside Biomedical, Inc. | 11 | 2013-02-01 | 2021-02-21 |
| Sirolimus as Therapeutic Approach to Uveitis Sirolimus (rapamycin) - Uveitis, Intermediate Uveitis | Phase 1 | Completed | Johns Hopkins University | 30 | 2009-07-01 | 2018-08-20 |
Uveitis, Intermediate (3) · Uveitis, Posterior (3) · Panuveitis (2) · Uveitis (2) · Choroidal Effusions (1) · Giant Cell Arteritis (1) · Inflammation (1) · Ophthalmia, Sympathetic (1)
Eye Diseases (3) · Uveal Diseases (3) · Arteritis (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Choroid Diseases (1) · Eye Abnormalities (1) · Immune System Diseases (1) · Nervous System Diseases (1) · Panuveitis (1) · Pathologic Processes (1)
Adrenal Cortex Hormones (1) · Sirolimus (1) · Triamcinolone (1) · Triamcinolone Acetonide (1) · tocilizumab (1)
Clearside Biomedical, Inc. (1) · Johns Hopkins University (1) · University of Nebraska (1)
United States (3)
Quan D Nguyen, MD, MSc (2) · Thomas Ciulla, MD (1)